In 2010, Genentech and Roche released a drug designed to treat Rheumatoid Arthritis (RA) and other similar autoimmune diseases. The medication, known as Actemra, was approved by the FDA but was not required to carry a black box warning label as many of the more recent RA drugs have done. This has been cause […]
Proton Pump Inhibitor MDL to be Reconsidered in July Hearing
People who have potential claims against manufacturers of proton pump inhibitors should know that the arguments for the motion to centralize the lawsuits into a multidistrict litigation (MDL) will be heard in July by the Judicial Panel on Multidistrict Litigation (JPMDL). This hearing will include 163 cases that have been filed against manufacturers of various […]
Invokana Lawsuit Plaintiffs Move to Consolidate
If you or someone you know is suffering from Type 2 Diabetes, you may have used a medication known as Invokana. You may therefore be eligible to file a claim as part of the multidistrict litigation that will be consolidated against the manufacturer of the drug. Wonder drug? Invokana is a drug developed, manufactured and […]